Christophe Le Terrier

29PUBLICATIONS
43CO-AUTHORS
Medical bacteriologyMicrobial ecologyMedical infection agents (incl. prions)Cheminformatics and quantitative structure-activity relationshipsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 23, 2026
In vitro activity of β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with aztreonam against metallo-β-lactamase producing Escherichia coli clinical isolates.

|Jul 25, 2025
Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations.

Lucía Sánchez-Peña, Salud Rodríguez-Pallares, Pablo Aja-Macaya

|Jun 09, 2025
The emerging concern of IMP variants being resistant to the only IMP-type metallo-β-lactamase inhibitor, xeruborbactam.

Christophe Le Terrier, Salvador I Drusin, Patrice Nordmann

|May 28, 2025
Inhibitory activity of meso-dimercaptosuccinic acid against IMP metallo-β-lactamase variants in Pseudomonas aeruginosa.

Jacqueline Findlay, Hector Moreno, Gilbert Greub

|Dec 20, 2024
In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022.

Christophe Le Terrier, Maxime Bouvier, Auriane Kerbol

|Nov 26, 2024
In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates.

Christophe Le Terrier, Otávio Hallal Ferreira Raro, Alaaeldin Mohamed Saad

Pageof 5

Frequent Collaborators

15 joint publications

Laurent Poirel

10 joint publications

Patrice Nordmann

3 joint publications

Alejandro J Vila

2 joint publications

Jacqueline Findlay